CaseBioscience® collaborates with Likarda on ARPA-H project, securing $7.3M for innovative room temperature storage of cell therapies, simplifying logistics.

CaseBioscience® is collaborating with a team awarded $7.3 million by ARPA-H to innovate cell therapy preservation without refrigeration, enhancing access to advanced treatments.

CaseBioscience is part of a team that received a $7.3 million grant from ARPA-H for groundbreaking work on preserving cell therapies at room temperature, enhancing accessibility.

CaseBioscience® has joined a multidisciplinary team awarded $7.3 million by ARPA-H to develop innovative methods for cell therapy product storage.

CaseBioscience® partners with Likarda to receive $7.3 million from ARPA-H for advancing ambient preservation in cell therapies, enhancing accessibility.

CaseBioscience is part of a multidisciplinary team receiving a $7.3 million grant from ARPA-H to advance room temperature cell therapy preservation technology.

CaseBioscience joins a multidisciplinary team awarded $7.3 million by ARPA-H to advance ambient preservation technologies for cell therapies.

CaseBioscience is part of a team that secured up to $7.3 million from ARPA-H to develop ambient preservation methods for cell therapies, aiming to simplify logistics.

CaseBioscience collaborates with Likarda's team for ARPA-H funding of $7.3 million, aiming to innovate ambient storage for cell therapies.

CaseBioscience® has launched innovative cryopreservation products at ATW 2026, enhancing biopreservation for cell therapies and ensuring better cell viability.

CaseBioscience introduces its advanced CaseBio™ products at ASRM 2025, marking a significant leap in Assisted Reproductive Technology following regulatory approvals.

Introducing cell therapy–grade cryopreservation and hypothermic storage solutions designed for consistency, quality, and performance across cell therapy workflows ST. PETERSBURG, Fla., Feb. 6, 2026 /PRNewswire/ -- CaseBioscience® announces the launch of CaseCryo® CTG DMSO , a...